What is Sunrest Lifescience Ltd. Quarterly Revenue?

Sunrest Lifescience Ltd. Quarterly Revenue Sunrest Lifescience Mar-2026 Quarterly Revenue is Rs 0 Cr which is growth of 0% YoY.

What is Sunrest Lifescience Ltd. Quarterly Net Profit?

Sunrest Lifescience Ltd. Quarterly Net Profit Sunrest Lifescience Mar-2026 Quarterly Net Profit is Rs 0 Cr which is growth of 0% YoY.

What is Sunrest Lifescience Ltd. Annual Revenue?

Sunrest Lifescience Ltd. Annual Revenue Sunrest Lifescience Mar-2026 Annual Revenue is Rs 33 Cr which is growth of 0.4% YoY.

What is Sunrest Lifescience Ltd. Annual Net Profit?

Sunrest Lifescience Ltd. Annual Net Profit Sunrest Lifescience Mar-2026 Annual Net Profit is Rs 3 Cr which is growth of 54.4% YoY.

What is Sunrest Lifescience Ltd. Total Shareholders Fund?

Sunrest Lifescience Ltd. Total Shareholders Fund Sunrest Lifescience Mar-2026 Total Shareholders Fund is Rs 19 Cr which is growth of 19.1% YoY.

What is Sunrest Lifescience Ltd. Total Assets?

Sunrest Lifescience Ltd. Total Assets Sunrest Lifescience Mar-2026 Total Assets is Rs 41 Cr which is growth of 17.6% YoY.

What is Sunrest Lifescience Ltd. Book Value Per Share?

Sunrest Lifescience Ltd. Book Value Per Share Sunrest Lifescience Mar-2026 Book Value Per Share is 45 Rs which is growth of 19.1% YoY.

What is Sunrest Lifescience Ltd. ROE?

Sunrest Lifescience Ltd. ROE Sunrest Lifescience Mar-2026 ROE is 16% which is growth of 3.7% YoY.

What is Sunrest Lifescience Ltd. Cash From Operating Activity?

Sunrest Lifescience Ltd. Cash From Operating Activity Sunrest Lifescience Mar-2026 Cash From Operating Activity is Rs -1 Cr which is growth of -147.7% YoY.

What is Sunrest Lifescience Ltd. Net Cash Flow?

Sunrest Lifescience Ltd. Net Cash Flow Sunrest Lifescience Mar-2026 Net Cash Flow is Rs 0 Cr which is growth of 2318.1% YoY.

Sunrest Lifescience Ltd.

NSE: SUNREST

Download real time

3.95(11.72%)

53.17% Gain from 52W Low

17,600

NSE Volume

High volume+gain today

NSE 16 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Sunrest Lifescience quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Sunrest Lifescience competitor comparison and performance snapshot within industry

Sunrest Lifescience annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Sunrest Lifescience Mar-2026 Annual Revenue is Rs 33 Cr which is growth of 0.4% YoY.
POSITIVE
Annual Net Profit Sunrest Lifescience Mar-2026 Annual Net Profit is Rs 3 Cr which is growth of 54.4% YoY.

Sunrest Lifescience Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21
SR_A Total Rev. Ann. ⌄	10.5%	14.4%	33.3	33.1	29.5	24.7	26.9	17
TotalOperatingRevenues_A Operating Rev. Ann.	10.6%	14.4%	33.3	33.1	29.5	24.6	26.9	17
OI_A Other Income Ann.	-	-				0	0
OEXPNS_A Operating Exp. Ann.	9.2%	11.2%	28.4	30.1	28.8	21.8	25.8	16.7
OEXPNS_A Operating Exp. Ann.	9.2%	11.2%	28.4	30.1	28.8	21.8	25.8	16.7
OP_A Operating Profit Ann.	18.3%	74.1%	4.8	3	0.7	2.9	1.1	0.3
OPMPCT_A OPM Ann. %	7.9%	56%	14.50%	9.06%	2.34%	11.53%	4.04%	1.57%
TotalExpenses_A Total Exp. Ann. ⌄	10.1%	11.8%	29.2	30.5	28.9	21.9	25.9	16.7
OtherExpenses_A Other Exp. Ann.	16.2%	14.1%	5.8	5.4	4.8	3.7	5.8	3
EmployeeBenefitExpenses_A Employee Exp. Ann.	21.2%	18.9%	5.7	4.9	3.8	3.2	2.5	2.4
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	18.3%	74.1%	4.8	3	0.7	2.9	1.1	0.3
EBIDTPCT_A EBITDA Ann. margin %	7.6%	56%	14.51%	9.06%	2.34%	11.65%	4.13%	1.57%
INT_A Interest Ann.	-	-	0.5	0.3
DEP_A Depr.	26%	-	0.2	0.1	0.1	0.1	0.1	0
PBT_A PBT Ann.	14.9%	83%	4.1	2.6	0.6	2.7	1.1	0.2
TAX_A Tax Ann.	12.6%	58.5%	1	0.6	0.4	0.7	0.3	0.1
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	15.7%	73%	3.1	2	0.2	2	0.8	0.2
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	15.7%	73%	3.1	2	0.2	2	0.8	0.2
NETPCT_A NPM Ann. %	3.8%	57.1%	9.28%	6.03%	0.76%	8.29%	2.89%	0.97%
EPS_adj_A EPS Adj. latest Ann.	14.5%	78.3%	3.6	2.3	0.3	2.4	0.9	0.2

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

0.6%

2Y CAGR

6.2%

3Y CAGR

10.5%

5Y CAGR

14.4%

Total Revenue Annual growth is lower than historical averages.

Net Profit Ann.

1Y CHG

55%

2Y CAGR

293.7%

3Y CAGR

15.7%

5Y CAGR

73%

Net Profit Annual growth is stable compared to historical averages.

Operating Exp. Ann.

1Y CHG

-5.6%

2Y CAGR

-0.7%

3Y CAGR

9.2%

5Y CAGR

11.2%

Operating Expenses Annual Cr is falling faster than historical averages.

Sunrest Lifescience balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Sunrest Lifescience Mar-2026 Total Shareholders Fund is Rs 19 Cr which is growth of 19.1% YoY.
POSITIVE
Total Assets Sunrest Lifescience Mar-2026 Total Assets is Rs 41 Cr which is growth of 17.6% YoY.

Sunrest Lifescience Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	84%	130%	19.3	16.2	14.2	3.1	1.1	0.3
EQCAP_A Equity Share Capital Ann.	12.7%	-	4.3	4.3	4.3	3	0	0
TotalShareCapital_A Total Share Capital Ann.	12.7%	-	4.3	4.3	4.3	3	0	0
ReservesAndSurplus_A Reserves Plus Surplus Ann.	431.3%	118.7%	15	11.9	9.9	0.1	1.1	0.3
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	431.3%	118.7%	15	11.9	9.9	0.1	1.1	0.3
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	58.1%	28%	7.9	4.4	3.5	2	3.1	2.3
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	-	-
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	-	-	0.4	0.3
CL_A Total Current Liabilities Ann. ⌄	7%	15.5%	14.2	14.6	7.5	11.6	8.9	6.9
TradePayables_A Trade Payables Ann.	8.6%	11.4%	11	11.4	3.8	8.6	7.9	6.4
OtherCurrentLiabilities_A Other Current Liabilities Ann.	-50%	14.9%	0.2	0.1	0.4	1.6	0.1	0.1
ShortTermProvisions_A ST Provisions Ann.	2.7%	34.1%	1.3	0.9	0.6	1.2	0.7	0.3
TL_A Total Capital Plus Liabilities Ann.	35.3%	34.2%	41.4	35.2	25.2	16.7	13	9.5
FixedAssets_A Fixed Assets Ann. ⌄	89%	68.3%	2.7	1.3	0.3	0.4	0.5	0.2
TangibleAssets_A Tangible Assets Ann.	89%	68.3%	2.7	1.3	0.3	0.4	0.5	0.2
IntangibleAssets_A Intangible Assets Ann.	-	-		0	0
CapitalWorkInProgress_A Capital Work In Progress Ann.	-	-
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	174.8%	110.7%	8.3	6.9	0.3	0.4	0.5	0.2
NonCurrentInvestments_A Non Current Investments Ann.	-	-	5.5	5.5	0	0
DeferredTaxAssets_A Deferred Tax Assets Ann.	-	-	0	0	0	0		0
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-	-
OtherNonCurrentAssets_A Other Non Current Assets Ann.	-	-	0	0	0	0
CA_A Total Current Assets Ann. ⌄	26.6%	28.9%	33.1	28.3	24.8	16.3	12.6	9.3
CurrentInvestments_A Current Investments Ann.	-	-
TradeReceivables_A Trade Receivables Ann.	19.5%	20.2%	18.6	19	15	10.9	9.4	7.4
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	-27.3%	4.6%	0.5	0.3	0.3	1.3	0.8	0.4
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	-	-	2.8	1.8	4.2
OtherCurrentAssets_A Other Current Assets Ann.	14.5%	-	0.3	0.4	0.3	0.2	0.1
TA_A Total Assets Ann.	35.3%	34.2%	41.4	35.2	25.2	16.7	13	9.5
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	-	-	0	0	0	0
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	0%	-	3	3	3	3
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	-	-	5.5	5.5	0	0
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

17.6%

2Y CAGR

28.2%

3Y CAGR

35.3%

5Y CAGR

34.2%

Total Assets Annual growth is lower than historical averages.

Total Current Liabilities Ann.

1Y CHG

-2.7%

2Y CAGR

37.6%

3Y CAGR

5Y CAGR

15.5%

Total Current Liabilities Annual Cr is falling faster than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

19.1%

2Y CAGR

16.6%

3Y CAGR

84%

5Y CAGR

130%

Total ShareHolders Funds Annual growth is lower than historical averages.

Sunrest Lifescience ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Sunrest Lifescience Mar-2026 Book Value Per Share is 45 Rs which is growth of 19.1% YoY.
POSITIVE
ROE Sunrest Lifescience Mar-2026 ROE is 16% which is growth of 3.7% YoY.

Sunrest Lifescience Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21
BVSH_A BVSH Ann.	62.8%	-31.4%	44.9	37.7	33.1	10.4	1,072	294.9
ROA_A RoA Ann. %	-15.2%	33.8%	7.46%	5.68%	0.89%	12.22%	5.96%	1.74%
ROE_A ROE Ann. %	-37.5%	-22.2%	16.02%	12.35%	1.59%	65.58%	72.49%	56.12%
ROCE_A ROCE Ann. %	-31.9%	14.3%	16.92%	14.12%	3.35%	53.67%	25.22%	8.69%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	7.5%	56%	14.50%	9.05%	2.34%	11.66%	4.12%	1.57%
PBITMargin_A EBIT Ann. Margin %	7.4%	60.1%	13.80%	8.78%	2.01%	11.13%	3.90%	1.31%
PBTMargin_A PBT Ann. Margin %	3.3%	56.4%	12.26%	7.87%	2.01%	11.13%	3.90%	1.31%
NETPCT_A NPM Ann. %	3.8%	57.1%	9.28%	6.03%	0.76%	8.29%	2.89%	0.97%
ASETTO_A Asset Turnover Ann. %	-19.1%	-	0.9	1.1	1.4	1.7	2.4	-
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	18%	10.4%	2.3	1.9	3.3	1.4	1.4	1.4
QuickRatio_A Quick Ratio Ann.	13.3%	7.8%	1.6	1.5	2.6	1.1	1.2	1.1
DividendPayoutNP_A Dividend Payout to NP Ann.	-	-	-	-	-	-	-	-
EarningRetention_A Earning Retention Ann. %	-	-
CashEarningRetention_A Cash Earning Retention Ann. %	-	-
CashEarningRetention_A Cash Earning Retention Ann. %	-	-
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	-	-	24.5	29	32.1
EVPerNetSales_A EV Per Net Sales Ann.	-	-	0.7	0.9	1.1	-	-	-
PBV_A Price To Book Value Adjusted	-36.3%	48.5%	0.94	1.02	1.14	3.63	0.04	0.13
EVPerEBITDA_A EV Per EBITDA Ann.	-	-	5.1	9.7	46.5	-	-	-
MarketCapPerSales_A Market Cap Per Sales Ann.	-	-	0.5	0.7	0.9	-	-	-
RetentionRatios_A Retention Ratio Ann. %	-	-
EYield_A Earnings Yield Ann.	-	-	0.2	0.1	0
DEBT_CE_A Total Debt to Total Equity Ann.	-10.6%	-42.4%	0.5	0.4	0.4	0.7	3	7.9

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

29.7%

2Y CAGR

217.4%

3Y CAGR

-37.5%

5Y CAGR

-22.2%

ROE Annual % is growing faster than historical averages.

RoA Ann. %

1Y CHG

31.3%

2Y CAGR

189.5%

3Y CAGR

-15.2%

5Y CAGR

33.8%

RoA Annual % is stable compared to historical averages.

Current Ratio Ann.

1Y CHG

21.1%

2Y CAGR

-16.5%

3Y CAGR

18%

5Y CAGR

10.4%

Current Ratio Annual growth is higher than historical averages.

Sunrest Lifescience cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Cash From Operating Activity Sunrest Lifescience Mar-2026 Cash From Operating Activity is Rs -1 Cr which is growth of -147.7% YoY.
POSITIVE
Net Cash Flow Sunrest Lifescience Mar-2026 Net Cash Flow is Rs 0 Cr which is growth of 2318.1% YoY.

Sunrest Lifescience Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21
CFO_A Cash from Operating Act. Ann. ⌄	-	-	-0.7	1.4	-14.8	1.2	-0.5	0.2
PBT_A PBT Ann.	14.9%	83%	4.1	2.6	0.6	2.7	1.1	0.2
INT_A Interest Ann.	-	-	0.5	0.3
TAX_A Tax Ann.	12.6%	58.5%	1	0.6	0.4	0.7	0.3	0.1
CFI_A Cash from Investing Act. Ann.	-	-	-1.6	-1.1	-0	-0	-0.4	-0.2
CFA_A Cash from Financing Act. Ann.	-	-	2.5	-0.3	14.6	-1.2	0.9	0
NCF_A Net Cash Flow Ann. ⌄	-	-	0.2	-0	-0.2	-0	0.1	0
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	-15.7%	0%	0.3	0.3	0.5	0.5	0.4	0.3
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	0%	4.6%	0.5	0.3	0.3	0.5	0.5	0.4

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Financing Act. Ann.

2Y CAGR

-58.6%

Cash from Financing Annual Activity growth is higher than historical averages.

Sunrest Lifescience investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

53.17% Gain from 52W Low

High volume+gain today

Sunrest Lifescience quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

Sunrest Lifescience - Competitors/Peers

Sunrest Lifescience competitor comparison and performance snapshot within industry

Sunrest Lifescience - Annual

Sunrest Lifescience annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Annual Revenue Sunrest Lifescience Mar-2026 Annual Revenue is Rs 33 Cr which is growth of 0.4% YoY.

Annual Net Profit Sunrest Lifescience Mar-2026 Annual Net Profit is Rs 3 Cr which is growth of 54.4% YoY.

Sunrest Lifescience - Balance Sheet

Sunrest Lifescience balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Total Shareholders Fund Sunrest Lifescience Mar-2026 Total Shareholders Fund is Rs 19 Cr which is growth of 19.1% YoY.

Total Assets Sunrest Lifescience Mar-2026 Total Assets is Rs 41 Cr which is growth of 17.6% YoY.

Sunrest Lifescience - Ratios

Sunrest Lifescience ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Book Value Per Share Sunrest Lifescience Mar-2026 Book Value Per Share is 45 Rs which is growth of 19.1% YoY.

ROE Sunrest Lifescience Mar-2026 ROE is 16% which is growth of 3.7% YoY.

Sunrest Lifescience - Cash Flow

Sunrest Lifescience cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Cash From Operating Activity Sunrest Lifescience Mar-2026 Cash From Operating Activity is Rs -1 Cr which is growth of -147.7% YoY.

Net Cash Flow Sunrest Lifescience Mar-2026 Net Cash Flow is Rs 0 Cr which is growth of 2318.1% YoY.

Sunrest Lifescience - Documents

Sunrest Lifescience investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access